Načítá se...
A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota
BACKGROUND: Successful chemoprevention or chemotherapy is achieved through targeted delivery of prophylactic agents during initial phases of carcinogenesis or therapeutic agents to malignant tumors. Bacteria can be used as anticancer agents, but efforts to utilize attenuated pathogenic bacteria suff...
Uloženo v:
| Vydáno v: | Microbiome |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8157686/ https://ncbi.nlm.nih.gov/pubmed/34039418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40168-021-01071-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|